Diabetes Care ; Systematic literature search described? Achirving, a shareable link Immune-boosting overall wellness not currently available for this article. The addition Oressure either a Eating time management or a CCB should be oprimal therapy in these patients to help achieve the BP goal. About American Journal of Hypertension Editorial Board Author Guidelines Facebook Twitter Purchase Recommend to your Library Advertising and Corporate Services Journals Career Network. In another study 32 of proteinuria, when an ACE inhibitor was combined with a long-acting dihydropyridine CCB, amlodipine, the results were more favorable than when the CCB was used as monotherapy.

Achieving optimal blood pressure goals -

The reasons for a low compliance and for such poor long-term adherence are diverse but in particular poor tolerability has been claimed as one of the most important. Table 2 summarises Guidelines directed to improve maintenance of antihypertensive therapy according to Norman Kaplan Cardiovascular and renal disease have been described as a continuum 32 starting with the detection of CV and renal risk factors, followed by the detection of target organ damage TOD and finally by ACC and eventually death.

It is clear that lifestyle interventions can clearly delay the development of hypertension as well as reduce CV risk, Table 1. It is inadequate for only physicians and health care professionals to discuss such issues.

Public health authorities need to intervene and set up an economic system that reinforces health behaviour. As a paradigm this has occurred in Finland with a dramatic reduction in the CV events within the last decade. Table 1 Lifestyle Modifications and Effects on Blood Pressure From Chobanian A et.

Legend Exercise caution over the use of high doses of diuretics. If a beta blocker is prescribed then it should be combined with a DHP CCB.

Other beta blockers are not excluded, however, there are no renal outcome data to support the use of atenolol in such patients and only limited data to support metoprolol AASK trial, Toprol XL. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

The JNC 7 Report. JAMA ; J Hypertens ; Trends in blood pressure control and antihypertensive treatment in clinical practice: the Brisighella Heart Study. Blood pressure control and physician management of hypertension in hospital hypertension units in Spain.

Hypertension ; Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. Evidence based management of hypertension : What to do when blood pressure is difficult to control.

BMJ ; Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study : a cohort study. Lancet ; Hypertensive vascular disease.

J Chronic Dis ; 1: Clinical inertia. Ann Intern Med ; Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Eng J Med ; Physiological aspects of primary hypertension.

Physiol Rev ; Role of endothelium-derived nitric oxide in the abnormal endotheliumdependent vascular relaxation of patients with essential hypertension.

Circulation ; Mild high-renin essential hypertension : neurogenic human hypertension? N Engl J Med ; Hyperkinetic borderline hypertension in Tecumseh, Michigan.

J Hypertens ;9: Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor : comparison with effects of a betablocker.

Am J Hypertens ; Comparison of effects of angiotensin I-converting enzyme inhibition and β-blockade for 2 years on function of small arteries from hypertensive patients. Impact of high-normal blood pressure on the risk of cardiovascular disease. Blood pressure usually considered as normal is associated with an elevated risk of cardiovascular disease.

Personalised single-pill combination therapy in hypertensive patients: an update of a practical treatment platform. CAS PubMed PubMed Central Google Scholar. ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients.

Download references. You can also search for this author in PubMed Google Scholar. Correspondence to Giuliano Tocci. Open access funding provided by Università degli Studi di Roma La Sapienza within the CRUI-CARE Agreement.

Supplementary file1 Flow-chart for the selection of the study population of hypertensive patients under monotherapies JPEG 64 kb.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material.

If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

Reprints and permissions. Tocci, G. et al. Blood Pressure Target Achievement Under Monotheraphy: A Real-Life Appraisal. High Blood Press Cardiovasc Prev 27 , — Download citation. Received : 23 September Accepted : 16 October Published : 09 November Issue Date : December Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Download PDF. Abstract Introduction Despite hypertension guidelines suggest that the most effective treatment strategy to improve blood pressure BP target achievement is to implement the use of combination treatment, monotherapy is still widely used in the clinical practice of hypertension.

Aim To investigate BP control under monotherapy in the setting of real-life. Results From an overall sample of records we selected Conclusions Our data showed a persistent use of monotherapy in the clinical practice, though with unsatisfactory BP control, especially in light of the BP treatment targets suggested by the last hypertension guidelines.

Management of Hypertension in Chronic Kidney Disease Article Open access 13 February RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus Article 01 October Racial and Ethnic Disparities in Hypertension: Barriers and Opportunities to Improve Blood Pressure Control Article 09 January Use our pre-submission checklist Avoid common mistakes on your manuscript.

Table 1 General characteristics of the study population of hypertensive outpatients treated with monotherapies Full size table. Full size image. Table 2 Office, home and h blood pressure levels in hypertensive outpatients treated with monotherapies Full size table.

References Dahlöf B, et al. PubMed Google Scholar Julius S, et al. CAS PubMed Google Scholar ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.

Google Scholar Jamerson K, et al. CAS PubMed Google Scholar Dahlöf B, et al. PubMed Google Scholar Chow CK, et al. CAS PubMed Google Scholar Borghi C, et al.

PubMed Google Scholar Tocci G, et al. CAS PubMed Google Scholar Geldsetzer P, et al. PubMed Google Scholar Volpe M, et al. CAS PubMed Google Scholar Williams B, et al. PubMed Google Scholar Volpe M, Gallo G, Tocci G. PubMed Google Scholar Del Pinto R, et al.

PubMed Google Scholar Torlasco C, et al. PubMed PubMed Central Google Scholar De Giusti M, et al. PubMed Google Scholar Rea F, et al. CAS PubMed Google Scholar Egan BM, et al. CAS PubMed Google Scholar Tocci G, et al. Google Scholar Mancia G, et al.

PubMed Google Scholar Expert Panel on Detection, and Treatment of High Blood Cholesterol in Adults. Google Scholar Rydén L, et al.

PubMed Google Scholar Thygesen K, et al. PubMed Google Scholar Goldstein LB, et al. PubMed Google Scholar Easton JD, et al. PubMed Google Scholar Cicero AFG, et al. CAS PubMed Google Scholar Thomopoulos C, Parati G, Zanchetti A. CAS PubMed Google Scholar Volpe M, et al. PubMed Google Scholar Wald DS, et al.

PubMed Google Scholar SPRINT Research Group. Google Scholar Tocci G, Volpe M. CAS PubMed Google Scholar Cuspidi C, et al. CAS PubMed Google Scholar Tadic M, Cuspidi C. PubMed Google Scholar Cuspidi C, et al. PubMed Google Scholar Tientcheu D, et al.

PubMed PubMed Central Google Scholar Cuspidi C, et al. CAS PubMed Google Scholar Mengden T, et al. CAS Google Scholar Hänninen MR, et al. PubMed Google Scholar Franklin SS, et al. CAS PubMed Google Scholar Mancia G, et al. CAS PubMed Google Scholar Presta V, et al.

Google Scholar Satoh M, et al. CAS PubMed PubMed Central Google Scholar Volpe M, et al. PubMed Google Scholar Download references. View author publications.

Ethics declarations Funding Open access funding provided by Università degli Studi di Roma La Sapienza within the CRUI-CARE Agreement. Conflict of interest The authors declare that they have no conflict of interest. Ethics approval Not applicable. Consent to participate Not applicable.

Consent for publication Not applicable. Code availability statements Not applicable. Electronic supplementary material. jpeg Supplementary file1 Flow-chart for the selection of the study population of hypertensive patients under monotherapies JPEG 64 kb. Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.

About this article. Cite this article Tocci, G. Copy to clipboard. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference.

This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.

search close. PREV Dec NEXT. From the AFP Editors. Consider Lower Targets to Reduce Myocardial Infarction. Barriers to Implementation. Implementation Techniques. Guideline source: American Academy of Family Physicians. Evidence rating system used? Systematic literature search described?

Guideline developed by participants without relevant financial ties to industry? Recommendations based on patient-oriented outcomes? arnold usuhs. This series is coordinated by Michael J. Arnold, MD, associate medical editor. Continue Reading.

Opitmal there is no cure, using medications as prescribed boood making lifestyle Immune-boosting overall wellness can enhance Hypertension and cancer risk quality of life presssure reduce your risk of gooals Immune-boosting overall wellness, stroke, kidney disease and more. Is your blood pressure in a healthy or an unhealthy range? The best way to know is to get your blood pressure checked. Maintaining an awareness of your numbers can alert you to any changes and help you detect patterns. Download a printable blood pressure log PDF. You and your health care professional are partners.

Video

Mayo Clinic Minute: Millions of Americans have hypertension under new blood pressure guidelines Achievijg hypertension guidelines suggest Immune-boosting overall wellness the prezsure effective treatment goaps to improve blood pressure BP target achievement is to goqls Immune-boosting overall wellness use of combination treatment, monotherapy is still widely used in the clinical practice of hypertension. Among treated hypertensive patients, we identified only those under single antihypertensive agent monotherapy. From an overall sample of records we selected In particular, All these proportions results significantly lower than those achieved with dual